217 filings
Page 7 of 11
8-K
yioyxlpow4lgdm 9leuh
7 Jul 05
Entry into a Material Definitive Agreement
12:00am
UPLOAD
aqgmw x135117nok
10 May 05
Letter from SEC
12:00am
8-K
q5idyqey6n
29 Apr 05
Entry into a Material Definitive Agreement
12:00am
UPLOAD
6hdaiu9xc
22 Apr 05
Letter from SEC
12:00am
8-K
dg7f7ffbq62 2pk
21 Apr 05
AtheroGenics Reports First Quarter 2005 Financial Results
12:00am
ARS
t0i376 43538l4
5 Apr 05
Annual report to shareholders
12:00am
8-K
w7zoxn65esd0jm
22 Feb 05
AtheroGenics Receives FDA Approval for Protocol Amendment to ARISE Phase III Clinical Trial
12:00am
8-K
z260yy1
16 Feb 05
AtheroGenics Reports Fourth Quarter and Full-Year 2004 Financial Results
12:00am
AW
wqn4l oczxawc
21 Jan 05
Withdrawal of amendment
12:00am
POS AM
sonnvjrr6rfpm 56
19 Jan 05
Prospectus update (post-effective amendment)
12:00am
8-K
jlnvp134 22vx8
13 Jan 05
Entry into a Material Definitive Agreement
12:00am
8-K
53g08ug3sb13ygc
11 Jan 05
Other Events
12:00am
8-K
4swdl5rl 59vy
7 Jan 05
AtheroGenics Prices Private Offering of Convertible Notes
12:00am